2006 Chronic Disease Diabetes Management 
Today's Hospitalist
JUNE 7, 2025
Key takeaways: Hospitalists will increasingly have to manage inpatients taking GLP-1s. THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. Based in Bucks County, Pa.,
GeriPal
MAY 1, 2025
There was some at the time, which was 2006 so also, it’s been a while since the guidance has been updated and other guidance for other viral infections like hepatitis B and C. I mean, treatment is really best done in a chronic or continuity setting, whether it’s in a primary care setting or some other.
Expert insights. Personalized for you.
66 
Let's personalize your content